Search

Solution NMR of synthetic analogues of nisin and mutacin ring A and ring B - Mutacin I Ring A truncated analogue
Authors
Dickman, R., Mitchell, S.A., Figueiredo, A., Hansen, D.F., Tabor, A.B.
Assembly
DAL-PRO-GLY-CYS-LYS
Entity
1. DAL-PRO-GLY-CYS-LYS (polymer), 6 monomers, 576.7066 Da Detail

XLSLCA


Formula weight
576.7066 Da
Source organism
Lactococcus lactis
Exptl. method
solution NMR
Refine. method
simulated annealing
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 83.3 %, Completeness: 54.3 %, Completeness (bb): 100.0 % Detail

Polymer type: polypeptide(L)

Total1H13C
All54.3 % (25 of 46)40.0 % (10 of 25)71.4 % (15 of 21)
Backbone100.0 % (25 of 25)100.0 % (10 of 10)100.0 % (15 of 15)
Sidechain19.2 % (5 of 26) 0.0 % (0 of 15)45.5 % (5 of 11)
Methyl10.0 % (1 of 10) 0.0 % (0 of 5)20.0 % (1 of 5)

1. entity 1

XLSLCA

Sample

Solvent system DMSO, Pressure 1 atm, Temperature 298 K, pH 5.0, Details 5.5 mg/mL Mutacin I Ring A truncated analogue, DMSO


#NameIsotope labelingTypeConcentration
1Mutacin I Ring A truncated analoguenatural abundance5.5 mg/mL

Protein Blocks Logo
Calculated from 15 models in PDB: 6QYT, Strand ID: A Detail


Release date
2019-09-26
Citation 1
A chemical biology approach to understanding molecular recognition of lipid II by nisin: Solid-phase synthesis and NMR ensemble analysis of nisin(1-12) and a synthetic ana-logue
Dickman, R., Danelius, E., Mitchell, S.A., Hansen, D.F., Erdelyi, M., Tabor, A.B.
Citation 2
Molecular Recognition of Lipid II by Lantibiotics: Synthesis and Conformational Studies of Analogues of Nisin and Mutacin Rings A and B
Dickman, R., Mitchell, S.A., Figueiredo, A.M., Hansen, D.F., Tabor, A.B.
J. Org. Chem. (2019), 84, 11493-11512, PubMed 31464129 , DOI 10.1021/acs.joc.9b01253 ,
Experiments performed 4 experiments Detail
Chemical shift validation 3 contents Detail
Keywords ANTIBIOTIC, ANTIMICROBIAL, BACTERIOCIN, LANTIBIOTIC, PEPTIDE ANTIBIOTIC, THIOESTER